vs

Side-by-side financial comparison of MEDIFAST INC (MED) and Offerpad Solutions Inc. (OPAD). Click either name above to swap in a different company.

Offerpad Solutions Inc. is the larger business by last-quarter revenue ($114.1M vs $75.1M, roughly 1.5× MEDIFAST INC). On growth, Offerpad Solutions Inc. posted the faster year-over-year revenue change (-34.5% vs -36.9%). Offerpad Solutions Inc. produced more free cash flow last quarter ($65.7M vs $-6.6M). Over the past eight quarters, MEDIFAST INC's revenue compounded faster (-34.4% CAGR vs -36.8%).

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

Offerpad Solutions Inc is a prominent U.S. proptech firm focused on simplifying residential real estate transactions. Operating under the iBuyer model, it purchases homes directly from sellers, conducts required renovations, and resells properties to buyers. It also provides supporting services including mortgage assistance, title services, and flexible moving options for clients across dozens of U.S. states.

MED vs OPAD — Head-to-Head

Bigger by revenue
OPAD
OPAD
1.5× larger
OPAD
$114.1M
$75.1M
MED
Growing faster (revenue YoY)
OPAD
OPAD
+2.4% gap
OPAD
-34.5%
-36.9%
MED
More free cash flow
OPAD
OPAD
$72.4M more FCF
OPAD
$65.7M
$-6.6M
MED
Faster 2-yr revenue CAGR
MED
MED
Annualised
MED
-34.4%
-36.8%
OPAD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MED
MED
OPAD
OPAD
Revenue
$75.1M
$114.1M
Net Profit
Gross Margin
69.4%
7.0%
Operating Margin
-10.4%
Net Margin
Revenue YoY
-36.9%
-34.5%
Net Profit YoY
49.1%
EPS (diluted)
$-1.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MED
MED
OPAD
OPAD
Q4 25
$75.1M
$114.1M
Q3 25
$89.4M
$132.7M
Q2 25
$105.6M
$160.3M
Q1 25
$115.7M
$160.7M
Q4 24
$119.0M
$174.3M
Q3 24
$140.2M
$208.1M
Q2 24
$168.6M
$251.1M
Q1 24
$174.7M
$285.4M
Net Profit
MED
MED
OPAD
OPAD
Q4 25
Q3 25
$-2.3M
$-11.6M
Q2 25
$2.5M
$-10.9M
Q1 25
$-772.0K
$-15.1M
Q4 24
$-17.3M
Q3 24
$1.1M
$-13.5M
Q2 24
$-8.2M
$-13.8M
Q1 24
$8.3M
$-17.5M
Gross Margin
MED
MED
OPAD
OPAD
Q4 25
69.4%
7.0%
Q3 25
69.5%
7.0%
Q2 25
72.6%
8.9%
Q1 25
72.8%
6.5%
Q4 24
74.1%
6.1%
Q3 24
75.4%
8.2%
Q2 24
73.2%
8.7%
Q1 24
72.8%
7.9%
Operating Margin
MED
MED
OPAD
OPAD
Q4 25
-10.4%
Q3 25
-4.6%
-5.1%
Q2 25
-1.0%
-4.9%
Q1 25
-1.1%
-7.2%
Q4 24
0.6%
-7.8%
Q3 24
1.5%
-4.3%
Q2 24
-4.7%
-3.9%
Q1 24
4.5%
-4.8%
Net Margin
MED
MED
OPAD
OPAD
Q4 25
Q3 25
-2.5%
-8.7%
Q2 25
2.3%
-6.8%
Q1 25
-0.7%
-9.4%
Q4 24
-9.9%
Q3 24
0.8%
-6.5%
Q2 24
-4.8%
-5.5%
Q1 24
4.8%
-6.1%
EPS (diluted)
MED
MED
OPAD
OPAD
Q4 25
$-1.64
Q3 25
$-0.21
$-0.37
Q2 25
$0.22
$-0.39
Q1 25
$-0.07
$-0.55
Q4 24
$0.08
$-0.64
Q3 24
$0.10
$-0.49
Q2 24
$-0.75
$-0.50
Q1 24
$0.76
$-0.64

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MED
MED
OPAD
OPAD
Cash + ST InvestmentsLiquidity on hand
$167.3M
$26.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$198.9M
$38.2M
Total Assets
$248.0M
$154.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MED
MED
OPAD
OPAD
Q4 25
$167.3M
$26.5M
Q3 25
$173.5M
$31.0M
Q2 25
$162.7M
$22.6M
Q1 25
$164.6M
$30.8M
Q4 24
$162.3M
$43.0M
Q3 24
$170.0M
$48.5M
Q2 24
$163.5M
$56.9M
Q1 24
$156.4M
$68.5M
Stockholders' Equity
MED
MED
OPAD
OPAD
Q4 25
$198.9M
$38.2M
Q3 25
$214.7M
$39.9M
Q2 25
$216.0M
$24.5M
Q1 25
$211.0M
$34.2M
Q4 24
$210.1M
$47.7M
Q3 24
$207.3M
$64.7M
Q2 24
$205.3M
$77.6M
Q1 24
$211.0M
$88.1M
Total Assets
MED
MED
OPAD
OPAD
Q4 25
$248.0M
$154.8M
Q3 25
$268.2M
$223.5M
Q2 25
$269.3M
$268.0M
Q1 25
$280.0M
$274.5M
Q4 24
$284.2M
$313.1M
Q3 24
$291.2M
$338.5M
Q2 24
$293.5M
$406.6M
Q1 24
$302.8M
$369.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MED
MED
OPAD
OPAD
Operating Cash FlowLast quarter
$-5.3M
$66.8M
Free Cash FlowOCF − Capex
$-6.6M
$65.7M
FCF MarginFCF / Revenue
-8.8%
57.6%
Capex IntensityCapex / Revenue
1.8%
0.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MED
MED
OPAD
OPAD
Q4 25
$-5.3M
$66.8M
Q3 25
$12.1M
$40.0M
Q2 25
$-3.4M
$-13.5M
Q1 25
$3.4M
$-10.2M
Q4 24
$-4.9M
$20.8M
Q3 24
$9.1M
$39.6M
Q2 24
$13.1M
$-54.4M
Q1 24
$7.3M
$2.4M
Free Cash Flow
MED
MED
OPAD
OPAD
Q4 25
$-6.6M
$65.7M
Q3 25
$10.8M
Q2 25
$-4.8M
$-13.6M
Q1 25
$1.9M
$-11.2M
Q4 24
$-7.2M
$15.4M
Q3 24
$7.7M
$38.7M
Q2 24
$11.1M
$-54.4M
Q1 24
$5.4M
$2.0M
FCF Margin
MED
MED
OPAD
OPAD
Q4 25
-8.8%
57.6%
Q3 25
12.0%
Q2 25
-4.5%
-8.5%
Q1 25
1.6%
-7.0%
Q4 24
-6.1%
8.9%
Q3 24
5.5%
18.6%
Q2 24
6.6%
-21.7%
Q1 24
3.1%
0.7%
Capex Intensity
MED
MED
OPAD
OPAD
Q4 25
1.8%
0.9%
Q3 25
1.5%
0.0%
Q2 25
1.3%
0.1%
Q1 25
1.3%
0.6%
Q4 24
1.9%
3.1%
Q3 24
1.0%
0.4%
Q2 24
1.1%
0.0%
Q1 24
1.1%
0.1%
Cash Conversion
MED
MED
OPAD
OPAD
Q4 25
Q3 25
Q2 25
-1.36×
Q1 25
Q4 24
Q3 24
8.04×
Q2 24
Q1 24
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons